NCT00623831 2022-10-25A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 AntigenLudwig Institute for Cancer ResearchPhase 1 Completed17 enrolled 14 charts
NCT02452424 2020-03-05A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid TumorsDaiichi SankyoPhase 1/2 Terminated78 enrolled 19 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts